ALIM — Alimera Sciences Share News
0.000.00%
Last trade - 00:00- $301.29m
- $360.44m
- $80.75m
Brief: Ani Pharmaceuticals Provides Update On Closing Of Acquisition Of Alimera Sciences
U.S. STOCKS ON THE MOVE-JPMorgan, automakers, energy firms
U.S. STOCKS ON THE MOVE-Arrowhead Pharma, Boeing, Centessa Pharma
Brief: Alimera Sciences Files Lawsuit To Compel ANI To Close Merger
Alimera Sciences down on filing lawsuit against ANI Pharma to close deal
Alimera Sciences Inc reports results for the quarter ended in June - Earnings Summary
Alimera Sciences Inc expected to post a loss of 1 cent a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Alimera Sciences, Comtech Telecommunications, Eli Lilly
U.S. STOCKS ON THE MOVE-Arrowhead Pharmaceuticals, Nvidia, Alimera Sciences
Alimera Sciences soars nearly 80% on ANI Pharma buyout
Brief: Ani Pharmaceuticals Expands Rare Disease Business Through Acquisition Of Alimera Sciences
Alimera Sciences Inc reports results for the quarter ended in March - Earnings Summary
Alimera Sciences Inc expected to post a loss of 6 cents a share - Earnings Preview
Alimera Sciences Inc reports results for the quarter ended in December - Earnings Summary
Brief: Alimera Sciences Says Co Entered Amendment To Loan & Security Deal
Brief: Alimera Sciences, Inc. Q4 net revenue USD 26.306 million
Brief: Alimera Sciences Appoints Todd Wood As President Of US Operations And Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Brief: Alimera Appoints Maggie A. Pax To Its Board Of Directors
Brief: Alimera Sciences, Inc. reports Q3 EPS USD -0.06